EUVIMEDEUVIMED entdecken
Crossref

Clinical usefulness of C-reactive protein-albumin-lymphocyte (CALLY) index as a prognostic biomarker in patients undergoing surgical resection of pancreatic cancer

Shinnosuke Kawahara, Toru Aoyama, Masaaki Murakawa, Rei Kanemoto, Naohiko Matsushita, Itaru Hashimoto, Mariko Kamiya, Yukio Maezawa, Satoshi Kobayashi, Makoto Ueno, Naoto Yamamoto, Takashi Oshima und 3 weitere

Langenbeck's Archives of Surgery · 2024

DOI: 10.1007/s00423-024-03512-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Langenbeck's Archives of Surgery, 2024. Verfasst von Shinnosuke Kawahara und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-Ku, Yokohama, 241-8515, Japan. kusoshin.0714@gmail.com. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, C-Reactive Protein, Biomarkers, Tumor. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The C-reactive protein-albumin-lymphocyte (CALLY) index, which simultaneously evaluates the nutritional, immunological, and inflammatory statuses, is a new prognostic biomarker in patients with various cancers; however, no study has reported the clinical significance of the CALLY index in patients with pancreatic cancer. This study aimed to investigate whether the preoperative CALLY index is a prognostic biomarker in patients undergoing surgical resection of pancreatic cancer. METHODS: We retrospectively enrolled 461 patients with pancreatic cancer who underwent surgical resection between January 2013 and December 2022. The overall survival (OS) and relapse-free survival (RFS) rates were calculated using the Kaplan-Meier method. Univariate and multivariate analyses were performed using Cox proportional hazards regression models. RESULTS: The optimal cut-off value for the preoperative CALLY index was 1.9. In the low CALLY group, patients were older (p = 0.012), more patients underwent pancreaticoduodenectomy (p = 0.002), the median tumor size was larger (p < 0.001), more patients had pathologically confirmed metastatic lymph nodes (p = 0.015) and worse pathological stage (p = 0.015), and fewer patients received adjuvant chemotherapy (p = 0.003). A low CALLY index was associated with decreased OS (22.1 vs. 37.9 months) and RFS (12.4 vs. 16.4 months). Univariate and multivariate analyses showed that the preoperative CALLY index was an independent prognostic factor for OS (p < 0.001) and RFS (p = 0.045). CONCLUSION: The preoperative CALLY index is a prognostic biomarker for both OS and RFS in patients undergoing surgery for pancreatic cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsC-Reactive ProteinBiomarkers, TumorHumansMaleFemaleRetrospective StudiesAgedMiddle AgedPrognosisPancreaticoduodenectomySerum AlbuminPancreatectomyLymphocytesLymphocyte Count

Stichwörter der Autor:innen

CALLY indexImmunological statusInflammatory statusNutritional statusPancreatic cancerSurvival

Substanzen

C-Reactive ProteinBiomarkers, TumorSerum Albumin

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-Ku, Yokohama, 241-8515, Japan. kusoshin.0714@gmail.com.
  • Department of Surgery, Yokohama City University, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
  • Department of Gastrointestinal Surgery, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-Ku, Yokohama, 241-8515, Japan.
  • Department of Gastroenterology, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-Ku, Yokohama, 241-8515, Japan.

Zitieren

APA

Kawahara, S., Aoyama, T., Murakawa, M., Kanemoto, R., Matsushita, N., Hashimoto, I., Kamiya, M., Maezawa, Y., Kobayashi, S., Ueno, M., Yamamoto, N., Oshima, T., Yukawa, N., Saito, A., & Morinaga, S. (2024). Clinical usefulness of C-reactive protein-albumin-lymphocyte (CALLY) index as a prognostic biomarker in patients undergoing surgical resection of pancreatic cancer. Langenbeck's Archives of Surgery. https://doi.org/10.1007/s00423-024-03512-8

Vancouver

Kawahara S, Aoyama T, Murakawa M, Kanemoto R, Matsushita N, Hashimoto I, et al. Clinical usefulness of C-reactive protein-albumin-lymphocyte (CALLY) index as a prognostic biomarker in patients undergoing surgical resection of pancreatic cancer. Langenbeck's Archives of Surgery. 2024. doi:10.1007/s00423-024-03512-8

BibTeX
@article{Kawahara2024,
  author = {Kawahara, Shinnosuke and Aoyama, Toru and Murakawa, Masaaki and Kanemoto, Rei and Matsushita, Naohiko and Hashimoto, Itaru and Kamiya, Mariko and Maezawa, Yukio and Kobayashi, Satoshi and Ueno, Makoto and Yamamoto, Naoto and Oshima, Takashi and Yukawa, Norio and Saito, Aya and Morinaga, Soichiro},
  title = {Clinical usefulness of C-reactive protein-albumin-lymphocyte (CALLY) index as a prognostic biomarker in patients undergoing surgical resection of pancreatic cancer},
  journal = {Langenbeck's Archives of Surgery},
  year = {2024},
  doi = {10.1007/s00423-024-03512-8}
}
Kostenlos starten →